You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug HEARTBURN RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing HEARTBURN RELIEF

Excipient Strategy and Commercial Opportunities for Heartburn Relief

Last updated: February 27, 2026

What excipients are critical for heartburn relief formulations?

The primary excipients in heartburn relief medications include:

  • Aluminum hydroxide and magnesium hydroxide: act as antacids to neutralize stomach acid.
  • Sorbitol or sodium bicarbonate: serve as buffers and taste-masking agents.
  • Coatings (e.g., hydroxypropyl methylcellulose): protect active ingredients, control release.
  • Binders and disintegrants (e.g., povidone, croscarmellose sodium): ensure tablet integrity and proper dissolution.
  • Flavoring agents (e.g., peppermint oil, artificial sweeteners): improve palatability.

The selection depends on formulation type—liquid, tablet, or chewable—and intended release profile.

How can excipient choices impact product differentiation?

Excipients influence taste, onset of action, stability, and bioavailability:

  • Taste-masking agents improve consumer acceptance; peppermint oil and artificial sweeteners are common.
  • Controlled-release excipients (e.g., gastro-resistant coatings) extend duration, reducing dosing frequency.
  • Buffer agents enhance stability, prevent degradation of acid-neutralizing compounds.

Differentiation options include adding slow-dissolving excipients for sustained relief or flavor profiles targeting specific demographics.

What are the regulatory considerations for excipient use?

Regulatory guidance for excipients in OTC heartburn products in the U.S. (FDA) and EU (EMA) specify:

  • Use of authorized excipients with established safety profiles.
  • Limits on excipient quantities, especially for pediatric formulations.
  • Clear labeling of excipient content, especially for allergenic ingredients like artificial sweeteners.

Novel excipients require preclinical safety data and regulatory approval, which can delay time-to-market.

What are the commercial opportunities linked to excipient innovation?

Opportunities include:

  • Developing taste-masked formulations for improved patient adherence.
  • Creating sustained-release products that minimize dosing frequency.
  • Using natural and plant-based excipients to appeal to clean-label trends.
  • Investing in sensitive and stable excipient systems for longer shelf life.

Market growth driven by consumer preference for OTC remedies with functional benefits. Innovation in excipients can allow for premium pricing, especially in formulations targeting chronic or severe reflux.

How do current market trends influence excipient strategy?

Growth in OTC heartburn medications remains steady, with the global market reaching approximately US$8.75 billion in 2022 (Grand View Research, 2022). Key trends include:

  • Increasing demand for low-sodium and all-natural excipients.
  • Preference for sugar-free, mint-flavored products.
  • Rising interest in biodegradable and plant-based excipients aligned with sustainability goals.
  • Expansion into differentiated dosage forms like dissolvable strips or chewables with innovative excipients.

Manufacturers must adapt excipient strategies to meet evolving consumer expectations and regulatory standards.

Summary table of excipient applications in heartburn relief formulations

Exipient Type Function Formulation Type Commercial Examples
Antacid salts Neutralize acid Liquids, chewables TUMS, Rolaids
Flavoring agents Mask bitter taste Chewables, liquids Pepto-Bismol, Mylanta
Coatings Extend release, protect API Tablets, capsules Omeprazole delayed-release capsules
Binders/disintegrants Enable tablet integrity Tablets Aluminum hydroxide tablets
Sweeteners Improve taste Chewables, syrups Artificial sweeteners, sorbitol

Key takeaways

  • Excipient choices directly impact product performance, stability, and consumer acceptance.
  • Differentiation hinges on taste-masking, sustained release, and natural ingredients.
  • Regulatory compliance influences excipient selection and labeling.
  • Innovation in excipients offers premium market opportunities aligned with consumer trends.
  • Market growth supports investment in novel, consumer-friendly excipient systems.

FAQs

1. Which excipients are most effective for taste-masking in heartburn remedies?
Artificial sweeteners such as aspartame or sucralose, along with flavoring agents like peppermint oil, effectively mask bitterness and improve palatability.

2. What regulatory challenges exist when introducing new excipients?
New excipients require safety evaluation, demonstrating equivalence or superiority to approved compounds, which can extend development timelines.

3. How does the choice of excipients influence the shelf life of heartburn relief products?
Stable excipients prevent degradation of active ingredients and maintain physical integrity, prolonging shelf life, especially in humid environments.

4. Are natural excipients gaining market traction?
Yes. Consumers prefer clean-label, plant-based excipients, influencing formulations and marketing strategies.

5. What future excipient trends could shape the heartburn relief market?
Biodegradable excipients, targeted sustained-release systems, and allergen-free flavoring agents are emerging trends.


References

[1] Grand View Research. (2022). Heartburn Treatment Market Size, Share & Trends Analysis Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.